
    
      Patients with primary pterygium will be randomly assigned to undertake pterygium excision
      followed by intraoperative mitomycin C application,amniotic membrane transplantation or
      conjunctival autograft in five clinical centers. Multi-center collaboration and quality
      monitoring will be based on a website designed for this study. The patients will be followed
      at least 12 months. Corneal Recurrence as the primary outcome measure, is considered as a
      fibrovascular ingrowth beyond the limbus with conjunctival drag.
    
  